Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
about
Identification of selectively expressed genes and antigens in CTCL.Proteome serological determination of tumor-associated antigens in melanoma.Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Melanoma: a prototype of cancer-testis antigen-expressing malignancies.Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.
P2860
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@ast
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@en
type
label
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@ast
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@en
prefLabel
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@ast
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@en
P2093
P2860
P1476
Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
@en
P2093
Eichmüller S
Gerhardt A
Schadendorf D
P2860
P304
P356
10.1046/J.1365-2133.2003.05410.X
P407
P577
2003-08-01T00:00:00Z